Lanean...
Understanding the In Vivo Fate of Radioimmunoconjugates for PET and SPECT
Over the past 25 years, antibodies have emerged as extraordinarily promising vectors for the delivery of radionuclides to tumors for nuclear imaging. While radioimmunoconjugates often produce very high activity concentrations in target tissues, they also are frequently characterized by elevated acti...
Gorde:
| Argitaratua izan da: | J Labelled Comp Radiopharm |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6432633/ https://ncbi.nlm.nih.gov/pubmed/29665104 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jlcr.3628 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|